ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), a subtype of breast cancer with the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), represents approximately 15–20% of all breast cancers (2).